Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Medulloblastoma 1

Interventions

Specimen Handling 123 Magnetic Resonance Spectroscopy 117 Cyclophosphamide 109 pembrolizumab 88 Radiotherapy 83 Nivolumab 73 Cisplatin 68 fludarabine 65 Biopsy 60 Carboplatin 59 Standard of Care 49 Radiosurgery 45 Gemcitabine 44 Paclitaxel 42 Dexamethasone 42 Radiation 39 Doxorubicin 39 Rituximab 38 Blood Specimen Collection 37 Bevacizumab 37 venetoclax 36 Cytarabine 36 Surveys and Questionnaires 35 fludarabine phosphate 33 Capecitabine 33 Temozolomide 31 Radiotherapy, Intensity-Modulated 31 Practice Guidelines as Topic 31 Ipilimumab 28 Interviews as Topic 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Vascular Endothelial Growth Factor A × 30 days × Clear all

NCT07346157 2026-06-01

PNOC044

University of California, San Francisco

Phase 1/2 Not yet recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡